Back to ABT
VANGUARD GROUP INC ABT Position History
Abbott Laboratories • Healthcare
Quarters held
25
Latest value
$3.4M
Q4 2025
Peak value
$22.4B
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $337M |
| Q1 2025 | $21.5B |
| Q1 2025 | $483.6M |
| Q1 2025 | $140M |
| Q1 2025 | $100.1M |
| Q1 2025 | $1.7M |
| Q2 2025 | $364.4M |
| Q2 2025 | $22.4B |
| Q2 2025 | $508.8M |
| Q2 2025 | $137.8M |
| Q2 2025 | $105.4M |
| Q2 2025 | $2.7M |
| Q3 2025 | $504.8M |
| Q3 2025 | $107.4M |
| Q3 2025 | $371.7M |
| Q3 2025 | $21B |
| Q3 2025 | $1.2B |
| Q3 2025 | $3.8M |
| Q4 2025 | $352.4M |
| Q4 2025 | $19.8B |
| Q4 2025 | $877 |
| Q4 2025 | $474.4M |
| Q4 2025 | $1.2B |
| Q4 2025 | $103M |
| Q4 2025 | $3.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $3.4M | 27.4K | — | — |
| Q4 2025 | $103M | 822.0K | — | — |
| Q4 2025 | $1.2B | 9.72M | — | — |
| Q4 2025 | $474.4M | 3.79M | — | — |
| Q4 2025 | $877 | 7 | — | — |
| Q4 2025 | $19.8B | 158.39M | — | — |
| Q4 2025 | $352.4M | 2.81M | — | — |
| Q3 2025 | $3.8M | 28.2K | — | — |
| Q3 2025 | $1.2B | 9.17M | — | — |
| Q3 2025 | $21B | 156.61M | — | — |
| Q3 2025 | $371.7M | 2.77M | — | — |
| Q3 2025 | $107.4M | 801.7K | — | — |
| Q3 2025 | $504.8M | 3.77M | — | — |
| Q2 2025 | $2.7M | 19.7K | — | — |
| Q2 2025 | $105.4M | 774.7K | — | — |
| Q2 2025 | $137.8M | 1.01M | — | — |
| Q2 2025 | $508.8M | 3.74M | — | — |
| Q2 2025 | $22.4B | 164.57M | — | — |
| Q2 2025 | $364.4M | 2.68M | — | — |
| Q1 2025 | $1.7M | 12.7K | — | — |
| Q1 2025 | $100.1M | 754.5K | — | — |
| Q1 2025 | $140M | 1.06M | — | — |
| Q1 2025 | $483.6M | 3.65M | — | — |
| Q1 2025 | $21.5B | 161.81M | — | — |
| Q1 2025 | $337M | 2.54M | — | — |
Other funds holding ABT
$10.7B
$10.5B
$10.3B
$8.7B
$8.7B
$8.5B
$8.2B